IJSR - International Journal of Scientific Research

Jonathan Soldera; Bruno Dellamea; Henrique Giovanardi

Volume : VIII, Issue : VIII, August - 2019

Nonalcoholic fatty liver disease and bariatric surgery: Where are we now?

Jonathan Soldera, Bruno Dellamea, Henrique Giovanardi

Abstract :

Non–alcoholic fatty liver disease prevalence has been increasing globally. This has been linked to an increase in the incidence of hepatocellular carcinoma with and without cirrhosis and of the need for liver transplantation in this group of patients. This translates into a considerable increase in costs in treatment for this condition. Bariatric surgery has been largely demonstrated to treat this disease with a high cost–benefit. Although, it is not currently recommended as co–morbidity for indication of surgery in patients with body mass index 35 to 39 Kg/m². The authors suggest in this editorial that non–alcoholic fatty liver disease with fiosis should be considered for inclusion as co–morbidity for indication of bariatric surgery.